verapamil has been researched along with Cystadenocarcinoma in 2 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Cystadenocarcinoma: A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Verapamil was found to enhance the cytotoxic effect of vincristine against ovarian cancer cells." | 1.28 | [In vitro drug-resistance decrease of ovarian cancer cells]. ( Lu, SM, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mizuno, K | 1 |
| Furuhashi, Y | 1 |
| Maeda, O | 1 |
| Iwata, M | 1 |
| Misawa, T | 1 |
| Kawai, M | 1 |
| Kano, T | 1 |
| Tomoda, Y | 1 |
| Lu, SM | 1 |
2 other studies available for verapamil and Cystadenocarcinoma
| Article | Year |
|---|---|
Mitomycin C cross-resistance induced by adriamycin in human ovarian cancer cells in vitro.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Cystadenocarcinoma; DNA, Neop | 1990 |
[In vitro drug-resistance decrease of ovarian cancer cells].
Topics: Cisplatin; Cystadenocarcinoma; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Fe | 1990 |